Koji Harada
Impact in
- Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
-
- Ubiquitin and proteasome pathways 5
- Cell death mechanisms and regulation 5
- Oncology 29
- Cancer-related Molecular Pathways 14
- Cancer Diagnosis and Treatment 6
- Co-authors
- Tarannum Ferdous (30 shared papers)Yoshiya Ueyama (24 shared papers)Yasuhiro Akai (10 shared papers)Mitsunobu Sato (13 shared papers)Masayuki Iwano (7 shared papers)Yoshihiko Saito (7 shared papers)Supriatno (16 shared papers)Hideo Yoshida (13 shared papers)
- Journals
- International Journal of Oncology (5 papers)Oral Oncology (5 papers)Oncology Reports (4 papers)Cancer Letters (3 papers)Acta Oto-Laryngologica (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Koji Harada
106 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Nephrology 273
- Otorhinolaryngology 120
- Cancer Research 316
- Oncology 374
- Molecular Biology 676
Countries citing papers authored by Koji Harada
This map shows the geographic impact of Koji Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Harada more than expected).
Fields of papers citing papers by Koji Harada
This network shows the impact of papers produced by Koji Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Harada. The network helps show where Koji Harada may publish in the future.
Co-authors
The 25 scholars most cited alongside Koji Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 230 | |
| 2 | 2009 | 148 | |
| 3 | 1997 | 116 | |
| 4 | 2007 | 94 | |
| 5 | 2005 | 89 | |
| 6 | 1986 | 86 | |
| 7 | 2004 | 66 | |
| 8 | 1997 | 59 | |
| 9 | 1991 | 59 | |
| 10 | 2016 | 56 | |
| 11 | 2002 | 42 | |
| 12 | 2018 | 40 | |
| 13 | 2004 | 40 | |
| 14 | 2002 | 35 | |
| 15 | 2015 | 32 | |
| 16 | Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. | 2005 | 32 |
| 17 | 2014 | 29 | |
| 18 | 2005 | 27 | |
| 19 | 1990 | 25 | |
| 20 | 2012 | 22 |
About Koji Harada
Koji Harada is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 113 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Oral health in cancer treatment (13 papers), Head and Neck Cancer Studies (12 papers), Vestibular and auditory disorders (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Nephrology (273 citations), Otorhinolaryngology (120 citations), Cancer Research (316 citations), Oncology (374 citations) and Molecular Biology (676 citations). Koji Harada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tarannum Ferdous, Yoshiya Ueyama, Yasuhiro Akai, Mitsunobu Sato, Masayuki Iwano, Yoshihiko Saito, Supriatno, Hideo Yoshida, Kimihiko Nakatani and Yukinari Yamaguchi. Their work appears in journals such as International Journal of Oncology, Oral Oncology, Oncology Reports, Cancer Letters and Acta Oto-Laryngologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.